Stocks Cut Losses, Gilead Covid-19 Treatment, ‘Buy American’ vs. ‘America First’, Disney Pushes Ahead with Reopening
The “Squawk on the Street” team discuss the market turn as stocks cut their losses. Gilead publishing new data on its antiviral drug remdesivir showing it reduced the risk of death for severely sick coronavirus patients by 62% compared with standard care alone. Goldman raises its Netflix target to the highest on the street, saying the stock could surge by more than 30% over the next year and is set to report a blowout second quarter. Plus, despite a surge in cases in Florida, Disney moves forward with its reopening plans. And the “Squawk on the Street” gang breaks down presumptive Democratic nominee Biden’s ‘Buy American’ economic plan, as President Trump calls it plagiarism.
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The “Squawk on the Street” team discuss the market turn as stocks cut their losses. Gilead publishing new data on its antiviral drug remdesivir showing it reduced the risk of death for severely sick coronavirus patients by 62% compared with standard care alone. Goldman raises its Netflix target to the highest on the street, saying the stock could surge by more than 30% over the next year and is set to report a blowout second quarter. Plus, despite a surge in cases in Florida, Disney moves forward with its reopening plans. And the “Squawk on the Street” gang breaks down presumptive Democratic nominee Biden’s ‘Buy American’ economic plan, as President Trump calls it plagiarism.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.